Biochemical and Histological Characterization of Sorcin Overexpression in Patients Who Underwent Radical Prostatectomy
Kenan Toprak, Mehmet Gokhan Culha, Huseyin Ozgur Kazan, Ayberk Iplikci, Gozde Kir, Gozde Ecem Cecikoglu, Ahmad Kado, Hayriye Erman, Asif Yildirim

TL;DR
This study found that sorcin levels are higher in prostate cancer patients compared to healthy individuals and may be linked to cancer severity.
Contribution
The study is the first to compare serum sorcin levels with histopathological findings in prostate cancer patients after radical prostatectomy.
Findings
Prostate cancer patients had significantly higher sorcin levels than healthy controls.
Higher sorcin levels were associated with positive lymph nodes and biochemical recurrence.
Sorcin levels correlated with higher cancer grade groups but not with staining percentages.
Abstract
Sorcin, a signaling molecule, has recently emerged as a significant focus within cancer research. This study aimed to compare histopathology results with serum sorcin level and tissue sorcin immunohistochemical expression in patients who underwent radical prostatectomy (RP). A total of 81 patients who underwent RP between December 2017 and June 2019 due to prostate cancer (PCa) and had not received any previous treatment were included in the study. Patients attended regular follow-up appointments for at least 24 months. In order to compare serum sorcin levels, the control group consisted of 67 healthy men. Demographic data of participants were recorded. In the PCa group, pathology data from both Transrectal ultrasound-guided biopsy and RP were documented. Prostate-specific antigen (PSA) and sorcin levels of PCa patients were found to be higher than the control group (P < .001, P =…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNatural Compound Pharmacology Studies
